T1	Participants 21 43	advanced breast cancer
T2	Participants 271 294	advanced breast cancers
T3	Participants 362 420	departments of medicine in eight French anticancer centres
T4	Participants 568 580	603 patients
T5	Participants 1103 1122	series of 240 cases
